Aditxt is trading 15% up at $0.01, apparently amplified by its extremely low share price and retail-driven interest, with no confirmed company-specific announcement identified for August 25, 2026.
- Current coverage continues to mention Nasdaq delisting concerns and Ignite Proteomics’ proposed $150 million SPAC transaction.
- Bullish retail sentiment and the Nasdaq Composite’s 0.78% gain may be supporting speculative micro-cap trading.
- Attribution remains low-confidence because no fresh catalyst directly explains the move.